Stay updated on rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check3 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check11 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check25 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.5%
- Check32 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.15.0 to v2.16.0. Additionally, options to save and download content have been added.SummaryDifference0.1%
- Check63 days agoChange DetectedThe page has removed extensive details about a Phase III clinical trial for idiopathic pulmonary fibrosis, including the study's objectives, inclusion and exclusion criteria, and specific treatment protocols. It has added a new revision number and a reference to an EudraCT number.SummaryDifference13%
Stay in the know with updates to rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rhPTX-2 for Idiopathic Pulmonary Fibrosis Clinical Trial page.